ITK independent development of Th17 responses during hypersensitivity pneumonitis driven lung inflammation

por Elmore, Jessica, Carter, Chavez, Redko, Amie, Koylass, Nicholas, Bennett, Amelia, Mead, Max, Ocasio-Rivera, Marinel, Huang, Weishan, Singh, Ankur, August, Avery
Publicado 2022

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy

por Ocasio-Rivera, Marinel, Marin-Maldonado, Frances, Trossi-Torres, Geraline, Ortiz-Rosado, Angely, Rodríguez-Irizarry, Valerie, Rodriguez-Lopez, Eric, Martínez, Sahayra, Almodóvar, Sharilyn, Suarez-Martínez, Edu
Publicado 2020